These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4706914)

  • 41. Effect of enterocoated cholestyramine on bowel habit after ileal resection: a double blind crossover study.
    Jacobsen O; Højgaard L; Hylander Møller E; Wielandt TO; Thale M; Jarnum S; Krag E
    Br Med J (Clin Res Ed); 1985 May; 290(6478):1315-8. PubMed ID: 3922471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Concentrations of cholestenoic acids in plasma from patients with reduced intestinal reabsorption of bile acids.
    Axelson M; Mörk B; Aly A; Walldius G; Sjövall J
    J Lipid Res; 1989 Dec; 30(12):1883-7. PubMed ID: 2621415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of bile salts on calcium absorption.
    Mudd AJ; Gibbons RA
    Res Vet Sci; 1969 Nov; 10(6):576-9. PubMed ID: 5368460
    [No Abstract]   [Full Text] [Related]  

  • 44. UTILIZATION OF FAT-SOLUBLE VITAMINS BY RATS AND CHICKS FED CHOLESTYRAMINE, A BILE ACID SEQUESTRANT.
    Whiteside CH; Harkins RW; Fluckiger HB; Sarett HP
    Am J Clin Nutr; 1965 Mar; 16():309-14. PubMed ID: 14263050
    [No Abstract]   [Full Text] [Related]  

  • 45. Cholestyramine alters bile acid amounts and the expression of cholesterol-related genes in rabbit intestinal and hepatic tissues.
    Qiu DN; Shang Q; Sun DY; Ding WQ; Luo ZG; Chen J; Jiang WR; Huang JP; Jiang XY
    J Dig Dis; 2017 Feb; 18(2):107-114. PubMed ID: 28067465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. THE INFLUENCE OF CHOLESTYRAMINE ON THE INTESTINAL ABSORPTION OF GLYCOCHOLIC ACID.
    BILLIAU A; VANDENBOSCH J
    Arch Int Pharmacodyn Ther; 1964 Jul; 150():46-51. PubMed ID: 14204504
    [No Abstract]   [Full Text] [Related]  

  • 47. Cholestyramine therapy for intractable diarrhea.
    Tamer MA; Santora TR; Sandberg DH
    Pediatrics; 1974 Feb; 53(2):217-20. PubMed ID: 4812005
    [No Abstract]   [Full Text] [Related]  

  • 48. Hypolipidemic drugs.
    Sirtori C; Fumagalli R; Paoletti R
    Adv Exp Med Biol; 1973; 38():171-98. PubMed ID: 4594063
    [No Abstract]   [Full Text] [Related]  

  • 49. Equilibrium and kinetic factors influencing bile sequestrant efficacy.
    Luner PE; Amidon GL
    Pharm Res; 1992 May; 9(5):670-6. PubMed ID: 1608901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of competing anions on binding of bile salts by cholestyramine.
    Kos R; White JL; Hem SL; Borin MT
    Pharm Res; 1991 Feb; 8(2):238-41. PubMed ID: 2023874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of treatment with a bile-sequestering agent (Secholex) on intestinal absorption, duodenal bile acids, and plasma lipids.
    Ritland S; Fausa O; Gjone E; Blomhoff JP; Skrede S; Lanner A
    Scand J Gastroenterol; 1975; 10(8):791-800. PubMed ID: 173015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of cholestyramine on bile composition and gallstones in hamsters and in man.
    Van der Linden W; Bergman F; Nakayama F
    Tijdschr Gastroenterol; 1969; 12(4):337-47. PubMed ID: 5362130
    [No Abstract]   [Full Text] [Related]  

  • 53. Short term reaction of biliary bile acids to cholestyramine medication.
    Juul AH; van der Linden W
    Acta Physiol Pharmacol Neerl; 1969; 15(4):469-79. PubMed ID: 5369266
    [No Abstract]   [Full Text] [Related]  

  • 54. Studies on human bile. V. Influence of cholestyramine treatment on the composition of bile in healthy subjects.
    Dam H; Prange I; Jensen M; Kallehauge HE; Fenger HJ
    Z Ernahrungswiss; 1971 Apr; 10(3):188-97. PubMed ID: 5581456
    [No Abstract]   [Full Text] [Related]  

  • 55. Cholestyramine, a Bile Acid Sequestrant, Increases Cecal Short Chain Fatty Acids and Intestinal Immunoglobulin A in Mice.
    Nishida S; Horinouchi A; Higashimura Y; Akahori R; Matsumoto K
    Biol Pharm Bull; 2020 Mar; 43(3):565-568. PubMed ID: 31852854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipid absorption, bile acids, and cholesterol metabolism in patients with chronic liver disease.
    Miettinen TA
    Gut; 1972 Sep; 13(9):682-9. PubMed ID: 4118161
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of cholestyramine, bile salt, and cholesterol feeding on the lipid composition of hepatic bile in man.
    Sarles H; Crotte C; Gerolami A; Mule A; Domingo N; Hauton J
    Scand J Gastroenterol; 1970; 5(7):603-8. PubMed ID: 5474430
    [No Abstract]   [Full Text] [Related]  

  • 58. Cholestyramine in dogs.
    Jansen GR; Zanetti ME
    J Pharm Sci; 1965 Jun; 54(6):863-7. PubMed ID: 5847019
    [No Abstract]   [Full Text] [Related]  

  • 59. SK&F 97426-A: a novel bile acid sequestrant with higher affinities and slower dissociation rates for bile acids in vitro than cholestyramine.
    Benson GM; Alston DR; Hickey DM; Jaxa-Chamiec AA; Whittaker CM; Haynes C; Glen A; Blanchard S; Cresswell SR; Suckling KE
    J Pharm Sci; 1997 Jan; 86(1):76-81. PubMed ID: 9002463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. EFFECT OF CHOLESTYRAMINE, A BILE ACID BINDING POLYMER, ON VITAMIN K1 ABSORPTION IN DOGS.
    ROBINSON HJ; KELLEY KL; LEHMAN EG
    Proc Soc Exp Biol Med; 1964 Jan; 115():112-5. PubMed ID: 14117411
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.